Welcome, Guest |
TOPIC:
9th Paris Hepatitis Conference 8 years 3 months ago #8078
The 9th Paris Hepatitis Conference took place this week (Jan 11-12): www.aphc.info/ The keynote question was How to Improve Access to Therapy? www.aphc.info/wp-content/uploads/2016/01...RO_PATRICK_LUNDI.pdf You can see some videos here: www.aphc.info/videos-2016/ Also, many of the slides are available on-line: www.aphc.info/materials-2016/ As you might expect, it is mostly rather "medical", but there are some interesting stats and web links about treatment criteria in different countries in the talk by Antonio Craxi: www.aphc.info/wp-content/uploads/2016/01...I_-_HCV_PHC_2016.pdf But unless I am mistaken, nobody mentioned generics...? Diagnosed Jan 2015: GT3, A0+F0/F1. Fatigue + Brain-Fog. Started Sof+Dac from fixHepC 10-Nov-2015. NO sides. Pre-Tx: AST 82, ALT 133, Viral Load 1 900 000. Week4: AST 47, ALT 58. VL < 15 (unquantifiable). Week12 (EOT): AST 30, ALT 26, VL UND Week16 (EOT+4): AST 32, ALT 28, GGT 24, VL UND Week28 (EOT+16): AST 26, ALT 22, GGT 24, VL UND Ever grateful to Dr James. Relapsed somewhere after all that... Bummer! Jan 2018: VL 63 000 (still GT3). | |
Time to create page: 0.158 seconds